Direct emissions
1,271
tCO2e
Explore carbon emissions data for ENTERO HEALTHCARE SOLUTIONS LIMITED. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for ENTERO HEALTHCARE SOLUTIONS LIMITED, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Total yearly emissions across all scopes
124,577 tCO2e
Scope 1
tCO2e
1,271
Scope 2
tCO2e
4,113
Scope 3 total
tCO2e
119,193
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Based on reported data, retrieved with AI
According to available emissions disclosures, ENTERO HEALTHCARE SOLUTIONS LIMITED reported total yearly emissions of 124,577 tCO₂e in 2025. Scope 3 emissions accounted for 96% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 0.6, placing it well below average for its sector for sustainability performance, and received a transparency score of 10.0, pointing to very little public detail on their key emissions.
Total Emissions across all scopes
124,577 tCO2e
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Direct emissions
1,271
tCO2eIndirect emissions from purchased energy, including electricity, heating and cooling.
Location based
4,113
tCO2eMarket based
–
tCO2eWider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
41,078
tCO2eCat 2
Capital goods
1,524
tCO2eCat 3
Fuel & energy related activities
1,524
tCO2eCat 4
Upstream transportation & distribution
1,524
tCO2eCat 5
Waste generated in operations
1,524
tCO2eCat 6
Business travel
1,524
tCO2eCat 7
Employee commuting
1,524
tCO2eCat 8
Upstream leased assets
1,524
tCO2eCat 9
Downstream transportation & distribution
1,524
tCO2eCat 10
Processing of sold products
1,524
tCO2eCat 11
Use of sold products
58,304
tCO2eCat 12
End-of-life treatment of sold products
1,524
tCO2eCat 13
Downstream leased assets
1,524
tCO2eCat 14
Franchises
1,524
tCO2eCat 15
Investments
1,524
tCO2e15 values were derived via Mycelium's normalisation process rather than reported by the company. Cells marked “–” were not disclosed.
Website
www.enterohealthcare.comAddress
PLOT NO. I-35, BUILDING - B,
INDUSTRIAL AREA PHASE - I,
13/7 MATHURA ROAD,
FARIDABAD
121003
Country
India
Jump straight into the sectors users explore most, or view all industries.
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. ENTERO HEALTHCARE SOLUTIONS LIMITED's score sits at the top of this page and in the score panel.
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
For ENTERO HEALTHCARE SOLUTIONS LIMITED, the single biggest gap is Use of sold products (Scope 3 Category 11). Mycelium estimates it accounts for around 47% of the company's total footprint, typically the largest source of emissions for a Retail company, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
Other material categories ENTERO HEALTHCARE SOLUTIONS LIMITED hasn't disclosed:
In total, roughly 80% of ENTERO HEALTHCARE SOLUTIONS LIMITED's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
In its 2025 reporting year, ENTERO HEALTHCARE SOLUTIONS LIMITED disclosed total emissions of 124,577 tCO2e across all scopes. Scope 3 accounted for the largest share, around 96% of the total.
For 2025, ENTERO HEALTHCARE SOLUTIONS LIMITED's available disclosure covers Scope 1 (1,271 tCO2e), Scope 2 (4,113 tCO2e). Figures not reported by the company are shown as modelled estimates and labelled as such.
ENTERO HEALTHCARE SOLUTIONS LIMITED has a Mycelium transparency score of 10 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. ENTERO HEALTHCARE SOLUTIONS LIMITED has a Mycelium Score of 0.6 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. ENTERO HEALTHCARE SOLUTIONS LIMITED disclosed 124,577 tCO2e for 2025, and its Mycelium Score of 0.6 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.